Stay updated on Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page.

Latest updates to the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 21, 2025.SummaryDifference0.6%
- Check45 days agoChange DetectedThe date has been updated from February 4, 2025, to March 21, 2025.SummaryDifference0.6%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe page has updated the status of a clinical trial from 'Recruiting' to 'Active, not recruiting', and has changed the date associated with the trial from July 7, 2023, to February 4, 2025.SummaryDifference8%
Stay in the know with updates to Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page.